chloral hydrate has been researched along with 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beuscher, N; Jeromin, J; Leuschner, J; Ritter, H; Schulz, HU; Schürer, M; Zimmermann, T | 1 |
| Bringmann, G; Fähr, S; Feineis, D; Fornadi, F; Fornadi, K; God, R | 1 |
| Bringmann, G; Feineis, D; God, R; Luborzewski, A; Moser, A; Riederer, F; Scholz, J | 1 |
1 trial(s) available for chloral hydrate and 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline
| Article | Year |
|---|---|
[The plasma level of the neurotoxin 1-trichloromethyl-1,2,4,5-tetrahydro-beta-carboline (TaClo) in man after oral administration of chloral hydrate].
Topics: Adult; Carbolines; Chloral Hydrate; Chromatography, High Pressure Liquid; Humans; Hypnotics and Sedatives; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry; Neurotoxins; Spectrophotometry, Infrared | 1998 |
2 other study(ies) available for chloral hydrate and 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline
| Article | Year |
|---|---|
Identification of the dopaminergic neurotoxin 1-trichloromethyl-1,2, 3,4-tetrahydro-beta-carboline in human blood after intake of the hypnotic chloral hydrate.
Topics: Administration, Oral; Aged; Aged, 80 and over; Carbolines; Chloral Hydrate; Female; Gas Chromatography-Mass Spectrometry; Humans; Hypnotics and Sedatives; Male; Neurotoxins; Parkinson Disease | 1999 |
Modification of tyrosine hydroxylase activity by chloral derived beta-carbolines in vitro.
Topics: Animals; Carbolines; Chloral Hydrate; Chromatography, High Pressure Liquid; Enzyme Activation; Humans; Levodopa; Nucleus Accumbens; Parkinson Disease; Rats; Tyrosine 3-Monooxygenase | 2002 |